LICENSE AGREEMENTLicense Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 9th, 2012 Company Industry JurisdictionThis License Agreement (the “Agreement”) is made effective this 29th day of December, 2005 by and between PAIN THERAPEUTICS, INC., a Delaware corporation with a principal place of business at 416 Browning Way, South San Francisco, CA 94080 (“PTI”) and KING PHARMACEUTICALS, INC., a Tennessee corporation with a principal place of business at 501 Fifth Street, Bristol, TN 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
COLLABORATION AGREEMENTCollaboration Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 9th, 2012 Company Industry JurisdictionThis COLLABORATION AGREEMENT is entered into as of November 9, 2005 (the “Effective Date”), by and between PAIN THERAPEUTICS, INC., a Delaware corporation having an address of 416 Browning Way, South San Francisco, California 94080 (“PTI”), and KING PHARMACEUTICALS, INC., a Tennessee corporation having an address of 501 Fifth Avenue, Bristol, Tennessee 37620 (“King”). Each of King and PTI is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
SEPTEMBER 21, 2011 FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • February 9th, 2012 • Pain Therapeutics Inc • Pharmaceutical preparations
Contract Type FiledFebruary 9th, 2012 Company IndustryRe: Lease Agreement dated December 28, 2010, by and between STONECLIFF OFFICE, L.P., as Lessor, and PAIN THERAPEUTICS, INC., as Lessee, (herein after referred to as the “Lease Agreement”), demising 5,679 rentable square feet of space locally known as Suite 260 in the StoneCliff building, located at 7801 Capital of Texas Highway, Austin, Travis County, Texas, 78731.